ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

An Efficacy and Safety Study of Palovarotene for the Treatment of MO

ClinicalTrials.gov ID: NCT03442985

Public ClinicalTrials.gov record NCT03442985. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 5:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Palovarotene in Subjects With Multiple Osteochondromas

Study identification

NCT ID
NCT03442985
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Clementia Pharmaceuticals Inc.
Industry
Enrollment
193 participants

Conditions and interventions

Interventions

  • Palovarotene 2.5 mg Drug
  • Palovarotene 5.0 mg Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
2 Years to 14 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 21, 2018
Primary completion
Mar 23, 2020
Completion
Oct 29, 2020
Last update posted
Jul 31, 2022

2018 – 2020

United States locations

U.S. sites
13
U.S. states
10
U.S. cities
12
Facility City State ZIP Site status
Children's Orthopaedic Center Los Angeles California 90027
Shriners Hospital for Children - Sacramento Sacramento California 95817
University of California-San Francisco San Francisco California 94158
Children's National Medical Center Washington D.C. District of Columbia 20010
The Paley Institute West Palm Beach Florida 330407
Shriners Hospital for Children - Chicago Chicago Illinois 60707
Johns Hopkins University Baltimore Maryland 21205
Boston Children's Hospital Boston Massachusetts 02115
Mayo Clinic - PPDS Rochester Minnesota 55905
Shriners Hospitals for Children - Portland Portland Oregon 97239
The Children's Hospital of Philadelphia (CHOP) Philadelphia Pennsylvania 19104
Shriners Hospital for Children - Philadelphia Philadelphia Pennsylvania 19410-4160
Memorial Hermann Hospital Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03442985, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 31, 2022 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03442985 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →